Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues

Front Endocrinol (Lausanne). 2021 Jan 26:11:610230. doi: 10.3389/fendo.2020.610230. eCollection 2020.

Abstract

Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.

Keywords: breast cancer; breast carcinoma; breast neuroendocrine neoplasms; neuroendocrine; review.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Female
  • Humans
  • Neuroendocrine Tumors / epidemiology
  • Neuroendocrine Tumors / pathology*
  • Neuroendocrine Tumors / therapy